Neoadjuvant Immunotherapy Improves Outcomes in Treatment of High-risk Liver Cancer
Patients diagnosed with liver cancer (hepatocellular carcinoma; HCC) who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not...
HighRisk
Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients
ABSTRACTObjectives: In the US, an estimated 37 million adults have chronic kidney disease (CKD). However, many lack awareness about CKD,...
Nearly 70% of High-Risk Patients Unaware of Chronic Kidney Disease Risk, Study Finds –
What You Should Know: – A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap...
